Rankings
▼
Calendar
ACLX Q3 2021 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena
ACLX
Arcellx, Inc.
$7B
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$17M
Net Income
-$17M
EPS (Diluted)
$-0.78
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$145M
Total Liabilities
$249M
Stockholders' Equity
-$104M
Cash & Equivalents
$70M
← FY 2021
All Quarters
Q4 2021 →